Literature DB >> 19652333

The Z isomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complex.

Vivian Cody1, Jim Pace, Lu Lin, Aleem Gangjee.   

Abstract

The crystal structure of the ternary complex of human dihydrofolate reductase (hDHFR) with NADPH and the Z isomer of 2,4-diamino-5-[2-(2'-methoxyphenyl)propenyl]-furo[2,3-d]pyrimidine (Z1) shows that the Z isomer binds in the normal antifolate orientation in which the furo oxygen occupies the 8-amino position observed in the binding of 2,4-diaminopteridine antifolates such as methotrexate and with the methoxyphenyl moiety cis to and coplanar with the furo[2,3-d]pyrimidine ring. The hDHFR ternary complex crystallized in the orthorhombic space group P2(1)2(1)2(1) and its structure was refined to 1.7 A resolution. Although other hDHFR complexes crystallize in this space group, these data provide only the second example of an unusual packing arrangement in which the conserved active-site Arg70 forms a salt bridge to the side chain of Glu44 from a symmetry-related molecule. As a result, the conformations of Phe31 and Gln35 shift with respect to those observed in the structure of mouse DHFR bound to Z1, which crystallizes in the monoclinic space group P2(1) and shows that Gln35 interacts with Arg70.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652333      PMCID: PMC2720327          DOI: 10.1107/S1744309109025548

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

1.  Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.

Authors:  Timothy M McPhillips; Scott E McPhillips; Hsiu-Ju Chiu; Aina E Cohen; Ashley M Deacon; Paul J Ellis; Elspeth Garman; Ana Gonzalez; Nicholas K Sauter; R Paul Phizackerley; S Michael Soltis; Peter Kuhn
Journal:  J Synchrotron Radiat       Date:  2002-11-01       Impact factor: 2.616

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

3.  An automated system to mount cryo-cooled protein crystals on a synchrotron beam line, using compact sample cassettes and a small-scale robot.

Authors:  Aina E Cohen; Paul J Ellis; Mitchell D Miller; Ashley M Deacon; R Paul Phizackerley
Journal:  J Appl Crystallogr       Date:  2002-12       Impact factor: 3.304

4.  Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.

Authors:  V Cody; N Galitsky; J R Luft; W Pangborn; A Rosowsky; R L Blakley
Journal:  Biochemistry       Date:  1997-11-11       Impact factor: 3.162

5.  Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.

Authors:  Vivian Cody; Joe R Luft; Walt Pangborn
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-01-19

6.  Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.

Authors:  Aleem Gangjee; Yibin Zeng; Michael Ihnat; Linda A Warnke; Dixy W Green; Roy L Kisliuk; Fu-Tyan Lin
Journal:  Bioorg Med Chem       Date:  2005-09-15       Impact factor: 3.641

7.  Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.

Authors:  V Cody; N Galitsky; J R Luft; W Pangborn; R L Blakley; A Gangjee
Journal:  Anticancer Drug Des       Date:  1998-06

8.  Comparison of ternary complexes of Pneumocystis carinii and wild-type human dihydrofolate reductase with coenzyme NADPH and a novel classical antitumor furo[2,3-d]pyrimidine antifolate.

Authors:  V Cody; N Galitsky; J R Luft; W Pangborn; A Gangjee; R Devraj; S F Queener; R L Blakley
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-11-01

9.  Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.

Authors:  J R Piper; C A Johnson; C A Krauth; R L Carter; C A Hosmer; S F Queener; S E Borotz; E R Pfefferkorn
Journal:  J Med Chem       Date:  1996-03-15       Impact factor: 7.446

10.  Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim.

Authors:  L F Kuyper; J M Garvey; D P Baccanari; J N Champness; D K Stammers; C R Beddell
Journal:  Bioorg Med Chem       Date:  1996-04       Impact factor: 3.641

View more
  3 in total

1.  Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.

Authors:  Vivian Cody; Jennifer Piraino; Jim Pace; Wei Li; Aleem Gangjee
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-11-16

2.  Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.

Authors:  Yongyuth Yuthavong; Bongkoch Tarnchompoo; Tirayut Vilaivan; Penchit Chitnumsub; Sumalee Kamchonwongpaisan; Susan A Charman; Danielle N McLennan; Karen L White; Livia Vivas; Emily Bongard; Chawanee Thongphanchang; Supannee Taweechai; Jarunee Vanichtanankul; Roonglawan Rattanajak; Uthai Arwon; Pascal Fantauzzi; Jirundon Yuvaniyama; William N Charman; David Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

3.  Molecular Characteristics and Serodiagnostic Potential of Dihydrofolate Reductase from Echinococcus granulosus.

Authors:  Xingju Song; Dandan Hu; Min Yan; Yu Wang; Ning Wang; Xiaobin Gu; Guangyou Yang
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.